Neuroendocrine tumours

Active Ingredient: Lanreotide

Indication for Lanreotide

Population group: only adults (18 years old or older)
Therapeutic intent: Curative procedure

The treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumours.

For this indication, competent medicine agencies globally authorize below treatments:

60-120 mg every 28 days

For:

Route of admnistration

Subcutaneous

Defined daily dose

60 - 120 mg

Dosage regimen

From 60 To 120 mg once every 28 day(s)

Detailed description

The recommended starting dose is 60 to 120 mg administered every 28 days.

The dose should be adjusted according to the degree of symptomatic relief obtained.

Dosage considerations

Deep subcutaneous injection in the superior external quadrant of the buttock or in the upper outer thigh. In case of self-injection the injection should be given in the upper outer thigh.

Regardless of the injection site, the skin should not be folded and the needle should be inserted rapidly and to its full length, perpendicularly to the skin. The injection site should alternate between the right and left side.

30 mg every 14 days

For:

Route of admnistration

Intramuscular

Defined daily dose

30 - 30 mg

Dosage regimen

From 30 To 30 mg once every 14 day(s)

Detailed description

Initially, one intramuscular injection should be given every 14 days.

The frequency of subsequent injections may be varied in accordance with the individual patient’s response (as judged by a reduction in symptoms and/or a reduction in GH and/or IGF-1 levels) such that injections can be given every 7 to 10 days as necessary.

Active ingredient

Lanreotide

Lanreotide is an octapeptide analogue of natural somatostatin. Like somatostatin, lanreotide is an inhibitor of various endocrine, neuroendocrine, exocrine and paracrine functions.

Read more about Lanreotide

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.